Core Insights - PENTAX Medical has entered into an asset purchase agreement with Merit Medical Systems for the acquisition of the C2 CryoBalloon technology, which aligns with its strategic focus on core flexible reusable endoscopy solutions [1][2][4] - The C2 CryoBalloon technology, which has been part of PENTAX Medical's portfolio since 2017, provides a minimally invasive treatment option for patients with Barrett's Esophagus and other gastrointestinal disorders [2][3] - The transition allows PENTAX Medical to concentrate on its core strengths while Merit Medical is expected to enhance the adoption and impact of the C2 technology [3][4] Company Overview - PENTAX Medical is a division of HOYA Group, specializing in flexible, reusable endoscopy solutions, and is committed to delivering high-quality imaging and intuitive solutions for healthcare professionals [5] - Merit Medical, founded in 1987, develops and distributes proprietary medical devices across various medical fields, including endoscopy, and employs approximately 7,300 individuals globally [6] - HOYA Corporation, established in 1941, is a leader in healthcare and technology innovation, providing advanced products for life care and supporting various industries with high-precision components [7]